Mineo Kurokawa
Overview
    Explore the profile of Mineo Kurokawa including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              502
            
            
              Citations
              6511
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Masuda Y, Honda A, Oyama T, Masamoto Y, Kurokawa M
  
  
    Int J Hematol
    . 2025 Mar;
    
    PMID: 40032737
  
  
          Fluid retention presenting as effusions in body cavities is sometimes encountered following allogeneic stem cell transplantation (allo-HSCT). It is unclear whether cavity effusions at independent sites may serve as cumulative...
      
2.
        
    
    Tokushige J, Taoka K, Nishikawa M, Jona M, Nakazaki K, Yatomi Y, et al.
  
  
    Int J Hematol
    . 2025 Feb;
    
    PMID: 39910008
  
  
          The incidence of leukemic conversion during the clinical course of paroxysmal nocturnal hemoglobinuria (PNH) has been reported to be 0.6-2.9%. Such an association is logically linked to the progression of...
      
3.
        
    
    Yasuda Y, Maki H, Shimura A, Honda A, Masamoto Y, Kurokawa M
  
  
    Int J Hematol
    . 2025 Feb;
          121(3):411-415.
    
    PMID: 39903436
  
  
          Type I cryoglobulinemia is typically associated with hematological malignancies such as B-cell lymphomas and plasma cell neoplasms. Its treatment basically targets underlying hematological malignancies, and the prognosis remains unsatisfactory. Despite...
      
4.
        
    
    Masuda Y, Honda A, Yasunaga Y, Kurokawa M
  
  
    Intern Med
    . 2025 Feb;
          64(3):435-438.
    
    PMID: 39894508
  
  
          CD19 chimeric antigen receptor (CAR) T-cell therapy is associated with potentially life-threatening immunological toxicities. We herein report an 81-year-old woman who experienced multiple perforations in the small intestine 8 days...
      
5.
        
    
    Oyama T, Honda A, Masuda Y, Morita K, Maki H, Masamoto Y, et al.
  
  
    Clin Transplant
    . 2025 Jan;
          39(1):e70072.
    
    PMID: 39761366
  
  
          Background: Pleural effusion and ascites developing after allogeneic hematopoietic stem cell transplantation (allo-SCT) are generally associated with inferior overall survival (OS); however, the prognostic value of pretransplant effusion on transplant...
      
6.
        
    
    Seki H, Morita K, Yamazaki S, Kurokawa M
  
  
    Intern Med
    . 2025 Jan;
          64(1):123-127.
    
    PMID: 39757000
  
  
          Methotrexate-associated lymphoproliferative disorder (MTX-LPD) constitutes a subset of lymphoid proliferations and lymphomas that are associated with immune deficiency and dysregulation. The clinical management of MTX-LPDs is contingent on their histopathological...
      
7.
        
    
    Shimomura Y, Kitamura T, Yanada M, Mizuno S, Kondo T, Yoshihara S, et al.
  
  
    Cytotherapy
    . 2024 Dec;
          27(3):316-323.
    
    PMID: 39625431
  
  
          Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only potentially curative treatment option for patients with refractory and relapsed acute myeloid leukemia (R/R AML) not in complete remission. Many...
      
8.
        
    
    Masuda Y, Morita K, Kurokawa M
  
  
    Rinsho Ketsueki
    . 2024 Nov;
          65(10):1247-1252.
    
    PMID: 39505548
  
  
          Primary central nervous system lymphoma (PCNSL) is a B-cell lymphoma confined to the CNS. In general, early initiation of treatment after diagnosis is considered to be associated with improved prognosis...
      
9.
        
    
    Inoue S, Ko T, Shindo A, Nomura S, Yamada T, Jimba T, et al.
  
  
    JACC Basic Transl Sci
    . 2024 Sep;
          9(8):956-967.
    
    PMID: 39297129
  
  
          Although clonal hematopoiesis of indeterminate potential (CHIP) is an adverse prognostic factor for atherosclerotic disease, its impact on nonischemic dilated cardiomyopathy (DCM) is elusive. The authors performed whole-exome sequencing and...
      
10.
        
    
    Masuda Y, Nara K, Fujii-Mori A, Shimura A, Taoka K, Watadani T, et al.
  
  
    Ann Hematol
    . 2024 Sep;
    
    PMID: 39269476
  
  
          Neurotoxicity associated with high-dose chemotherapy and whole brain radiotherapy (WBRT) is one of major complications for patients with central nervous system lymphoma (CNSL). Here we determined the incidence and risk...